Point of Care (POC) HIV Testing Market Size, Share, Trends, Growth Outlook

Point of Care (POC) HIV Testing Market is estimated to increase at a growth rate of 4.1% CAGR over the forecast period from 2024 to 2030.

The global Point of Care (POC) HIV Testing Market Study analyzes and forecasts the market size across 6 regions and 24 countries for diverse segments including By Product (POC HIV testing equipment, POC HIV testing reagents), By End-User (Diagnostic labs, Hospitals and clinics, Others).

An Introduction to Point of Care (POC) HIV Testing Market in 2024

The Point-of-Care (POC) HIV Testing Market in 2024 represents a transformative approach to HIV screening and diagnosis, offering rapid and accessible testing solutions for the detection of HIV antibodies and antigens at the point of care. POC HIV testing devices enable healthcare providers to perform on-the-spot screening tests using oral fluid, blood, or plasma specimens, thus facilitating early diagnosis, linkage to care, and prevention strategies in diverse clinical and community settings. With HIV/AIDS remaining a global public health priority, particularly in high-prevalence regions and key populations at risk of infection, the POC HIV testing market witnesses rapid expansion and technological innovation, driven by factors such as advancements in lateral flow immunoassays, nucleic acid amplification tests (NAATs), and microfluidic technologies. Moreover, as stakeholders in HIV prevention and treatment embrace the "test and treat" paradigm, targeted outreach, and community-based testing initiatives, the POC HIV testing market plays a pivotal role in achieving the goals of the global HIV/AIDS response, including epidemic control, elimination of mother-to-child transmission, and ending the HIV/AIDS pandemic by 2030.

Point of Care (POC) HIV Testing Market Competitive Landscape

The global Point of Care (POC) HIV Testing Industry is highly competitive with a large number of companies focusing on niche market segments. Amidst intense competitive conditions, Point of Care (POC) HIV Testing Companies are investing in new product launches and strengthening distribution channels. Key companies operating in the Point of Care (POC) HIV Testing Industry include- AltraTech Ltd, Becton, Dickinson and Company, binx health Inc, bioMerieux SA, Cochrane, Community Pharmacy England, CVS Health Corp, Danaher Corp, DrSafeHands, F. Hoffmann La Roche Ltd, Island Health, J. Mitra and Co. Pvt. Ltd, MH Sub I LLC, Orchard Healthcare Pvt. Ltd.

Point of Care HIV Testing Market Trend: Expansion of Rapid Point-of-Care (POC) HIV Testing Programs

The expansion of rapid Point-of-Care (POC) HIV testing programs is a prominent trend shaping the Point of Care HIV Testing market. Rapid HIV tests offer advantages such as quick results, minimal invasiveness, and ease of use, making them valuable tools for HIV screening and diagnosis in various healthcare settings, including clinics, community centers, and outreach programs. Governments, non-profit organizations, and public health agencies are increasingly implementing POC HIV testing initiatives to reach underserved populations, reduce barriers to testing, and promote early detection of HIV infection. By facilitating widespread access to rapid HIV testing, these programs contribute to HIV prevention efforts, linkage to care, and public health surveillance, driving market demand and adoption of POC HIV testing technologies.

Point of Care HIV Testing Market Driver: Global Efforts to Achieve UNAIDS 90-90-90 Targets

Global efforts to achieve UNAIDS 90-90-90 targets are significant drivers fueling the demand for Point of Care HIV Testing. The UNAIDS 90-90-90 targets aim to diagnose 90% of all people living with HIV, provide antiretroviral therapy (ART) to 90% of those diagnosed, and achieve viral suppression in 90% of those on ART by 2020. Achieving these targets is critical for controlling the HIV epidemic, reducing HIV-related morbidity and mortality, and ending AIDS as a public health threat by 2030. POC HIV testing plays a central role in achieving the first 90 target by increasing HIV testing coverage, promoting early diagnosis, and facilitating timely linkage to care and treatment initiation for individuals who test positive. With the global commitment to ending the HIV/AIDS epidemic and achieving universal access to HIV testing and treatment services, there is a growing demand for rapid, accurate, and accessible POC HIV testing solutions to support HIV prevention, care, and treatment efforts worldwide. As countries intensify their efforts to scale up HIV testing and treatment programs, the demand for Point of Care HIV Testing devices is expected to increase, driving market growth and investment in POC testing technologies.

Point of Care HIV Testing Market Opportunity: Integration with Digital Health Platforms for Remote Monitoring and Support Services

The Market Opportunity for Point of Care HIV Testing lies in its integration with digital health platforms for remote monitoring and support services. Digital health technologies offer opportunities to enhance HIV testing and treatment services, improve patient engagement, and optimize healthcare delivery models. POC HIV testing devices equipped with wireless connectivity, smartphone integration, and cloud-based data analytics capabilities enable patients to perform self-testing, receive instant results, and access support services such as counseling, linkage to care, and medication adherence support remotely. Additionally, digital health platforms offer features such as virtual consultations, peer support networks, and personalized health coaching to empower individuals living with HIV to manage their condition effectively and achieve viral suppression. By leveraging remote monitoring and support services, manufacturers of Point of Care HIV Testing devices can address unmet patient needs, improve care continuum outcomes, and enhance HIV prevention and treatment efforts, driving market growth and innovation in HIV diagnostics and care.

Point of Care HIV Testing Market Share Analysis: Equipment is the fastest growing market segment over the forecast period to 2030

POC HIV Testing Equipment emerges as the rapidly expanding product within the Point of Care HIV Testing market. This growth is driven by several crucial factors. Firstly, the increasing emphasis on early detection and management of HIV/AIDS globally has propelled the demand for efficient and accessible testing solutions. POC testing equipment offers the advantage of providing rapid results, enabling timely diagnosis and immediate initiation of treatment, which is critical for improving patient outcomes and preventing further transmission. Additionally, advancements in testing equipment technology have led to the development of more compact and user-friendly devices, making them suitable for use in various healthcare settings, including diagnostic labs, hospitals, and clinics. Moreover, the growing awareness about the importance of HIV testing and the expansion of testing programs in community settings further contribute to the adoption of POC testing equipment. With their ability to provide quick and reliable HIV testing, POC testing equipment represents a vital tool in the global effort to combat HIV/AIDS, offering opportunities for improved healthcare delivery and disease control.

Point of Care (POC) HIV Testing Market Segmentation

By Product
POC HIV testing equipment
POC HIV testing reagents
By End-User
Diagnostic labs
Hospitals and clinics
Others
Geographical Analysis
North America (United States, Canada, Mexico)
Europe (Germany, France, United Kingdom, Spain, Italy, Rest of Europe)
Asia Pacific (China, India, Japan, South Korea, Rest of Asia Pacific)
South America (Brazil, Argentina, Rest of South America)
Middle East and Africa (Saudi Arabia, UAE, Rest of Middle East, South Africa, Egypt, Rest of Africa)

Point of Care (POC) HIV Testing Companies

AltraTech Ltd
Becton, Dickinson and Company
binx health Inc
bioMerieux SA
Cochrane
Community Pharmacy England
CVS Health Corp
Danaher Corp
DrSafeHands
F. Hoffmann La Roche Ltd
Island Health
J. Mitra and Co. Pvt. Ltd
MH Sub I LLC
Orchard Healthcare Pvt. Ltd
* List not Exhaustive

Reasons to Buy the Point of Care (POC) HIV Testing Market Study

• Deepen your industry insights and navigate uncertainties for strategy formulation, CAPEX, and Operational decisions
• Gain access to detailed insights on the Point of Care (POC) HIV Testing Market, encompassing current market size, growth trends, and forecasts till 2030.
• Access detailed competitor analysis, enabling competitive advantage through a thorough understanding of market players, strategies, and potential differentiation opportunities
• Stay ahead of the curve with insights on technological advancements, innovations, and upcoming trends
• Identify lucrative investment avenues and expansion opportunities within the Point of Care (POC) HIV Testing Industry, guided by robust, data-backed analysis.
• Understand regional and global markets through country-wise analysis, regional market potential, regulatory nuances, and dynamics
• Execute strategies with confidence and speed through information, analytics, and insights on the industry value chain
• Corporate leaders, strategists, financial experts, shareholders, asset managers, and governmental representatives can make long-term planning scenarios and build an integrated and timely understanding of market dynamics
• Benefit from tailored solutions and expert consultation based on report insights, providing personalized strategies aligned with specific business needs.

TABLE OF CONTENTS

1 Introduction to 2024 Point of Care (POC) HIV Testing Market
1.1 Market Overview
1.2 Quick Facts
1.3 Scope/Objective of the Study
1.4 Market Definition
1.5 Countries and Regions Analyzed
1.6 Units, Currency, and Conversions
1.7 Industry Value Chain

2 Research Methodology
2.1 Market Size Estimation
2.2 Sources and Research Methodology
2.3 Data Triangulation
2.4 Assumptions and Limitations

3 Executive Summary
3.1 Global Point of Care (POC) HIV Testing Market Size Outlook, $ Million, 2021 to 2030
3.2 Point of Care (POC) HIV Testing Market Outlook by Type, $ Million, 2021 to 2030
3.3 Point of Care (POC) HIV Testing Market Outlook by Product, $ Million, 2021 to 2030
3.4 Point of Care (POC) HIV Testing Market Outlook by Application, $ Million, 2021 to 2030
3.5 Point of Care (POC) HIV Testing Market Outlook by Key Countries, $ Million, 2021 to 2030

4 Market Dynamics
4.1 Key Driving Forces of Point of Care (POC) HIV Testing Industry
4.2 Key Market Trends in Point of Care (POC) HIV Testing Industry
4.3 Potential Opportunities in Point of Care (POC) HIV Testing Industry
4.4 Key Challenges in Point of Care (POC) HIV Testing Industry

5 Market Factor Analysis
5.1 Value Chain Analysis
5.2 Competitive Landscape
5.2.1 Global Point of Care (POC) HIV Testing Market Share by Company (%), 2023
5.2.2 Product Offerings by Company
5.3 Porter’s Five Forces Analysis
5.4 Pricing Analysis and Outlook

6 Growth Outlook Across Scenarios
6.1 Growth Analysis-Case Scenario Definitions
6.2 Low Growth Scenario Forecasts
6.3 Reference Growth Scenario Forecasts
6.4 High Growth Scenario Forecasts

7 Global Point of Care (POC) HIV Testing Market Outlook by Segments
7.1 Point of Care (POC) HIV Testing Market Outlook by Segments, $ Million, 2021- 2030
By Product
POC HIV testing equipment
POC HIV testing reagents
By End-User
Diagnostic labs
Hospitals and clinics
Others
8 North America Point of Care (POC) HIV Testing Market Analysis and Outlook To 2030
8.1 Introduction to North America Point of Care (POC) HIV Testing Markets in 2024
8.2 North America Point of Care (POC) HIV Testing Market Size Outlook by Country, 2021-2030
8.2.1 United States
8.2.2 Canada
8.2.3 Mexico
8.3 North America Point of Care (POC) HIV Testing Market size Outlook by Segments, 2021-2030
By Product
POC HIV testing equipment
POC HIV testing reagents
By End-User
Diagnostic labs
Hospitals and clinics
Others
9 Europe Point of Care (POC) HIV Testing Market Analysis and Outlook To 2030
9.1 Introduction to Europe Point of Care (POC) HIV Testing Markets in 2024
9.2 Europe Point of Care (POC) HIV Testing Market Size Outlook by Country, 2021-2030
9.2.1 Germany
9.2.2 France
9.2.3 Spain
9.2.4 United Kingdom
9.2.4 Italy
9.2.5 Russia
9.2.6 Norway
9.2.7 Rest of Europe
9.3 Europe Point of Care (POC) HIV Testing Market Size Outlook by Segments, 2021-2030
By Product
POC HIV testing equipment
POC HIV testing reagents
By End-User
Diagnostic labs
Hospitals and clinics
Others
10 Asia Pacific Point of Care (POC) HIV Testing Market Analysis and Outlook To 2030
10.1 Introduction to Asia Pacific Point of Care (POC) HIV Testing Markets in 2024
10.2 Asia Pacific Point of Care (POC) HIV Testing Market Size Outlook by Country, 2021-2030
10.2.1 China
10.2.2 India
10.2.3 Japan
10.2.4 South Korea
10.2.5 Indonesia
10.2.6 Malaysia
10.2.7 Australia
10.2.8 Rest of Asia Pacific
10.3 Asia Pacific Point of Care (POC) HIV Testing Market size Outlook by Segments, 2021-2030
By Product
POC HIV testing equipment
POC HIV testing reagents
By End-User
Diagnostic labs
Hospitals and clinics
Others
11 South America Point of Care (POC) HIV Testing Market Analysis and Outlook To 2030
11.1 Introduction to South America Point of Care (POC) HIV Testing Markets in 2024
11.2 South America Point of Care (POC) HIV Testing Market Size Outlook by Country, 2021-2030
11.2.1 Brazil
11.2.2 Argentina
11.2.3 Rest of South America
11.3 South America Point of Care (POC) HIV Testing Market size Outlook by Segments, 2021-2030
By Product
POC HIV testing equipment
POC HIV testing reagents
By End-User
Diagnostic labs
Hospitals and clinics
Others
12 Middle East and Africa Point of Care (POC) HIV Testing Market Analysis and Outlook To 2030
12.1 Introduction to Middle East and Africa Point of Care (POC) HIV Testing Markets in 2024
12.2 Middle East and Africa Point of Care (POC) HIV Testing Market Size Outlook by Country, 2021-2030
12.2.1 Saudi Arabia
12.2.2 UAE
12.2.3 Oman
12.2.4 Rest of Middle East
12.2.5 Egypt
12.2.6 Nigeria
12.2.7 South Africa
12.2.8 Rest of Africa
12.3 Middle East and Africa Point of Care (POC) HIV Testing Market size Outlook by Segments, 2021-2030
By Product
POC HIV testing equipment
POC HIV testing reagents
By End-User
Diagnostic labs
Hospitals and clinics
Others
13 Company Profiles
13.1 Company Snapshot
13.2 SWOT Profiles
13.3 Products and Services
13.4 Recent Developments
13.5 Financial Profile
List of Companies
AltraTech Ltd
Becton, Dickinson and Company
binx health Inc
bioMerieux SA
Cochrane
Community Pharmacy England
CVS Health Corp
Danaher Corp
DrSafeHands
F. Hoffmann La Roche Ltd
Island Health
J. Mitra and Co. Pvt. Ltd
MH Sub I LLC
Orchard Healthcare Pvt. Ltd
14 Appendix
14.1 Customization Offerings
14.2 Subscription Services
14.3 Related Reports
14.4 Publisher Expertise

By Product
POC HIV testing equipment
POC HIV testing reagents
By End-User
Diagnostic labs
Hospitals and clinics
Others